Jan 22nd, 2024
Final Late-Breaking Science announced for ISC 2024
See the impressive lineup of Late-Breaking Science on tap for presentation in Phoenix.
Opening Main Event | 11 a.m.-12:30 p.m. | Wednesday, Feb. 7
- Zero Degree Head Positioning in Acute Large Vessel Ischemic Stroke (ZODIAC)
- Randomization of Endovascular Treatment with Stent-Retriever and/or Thromboaspiration vs. Best Medical Therapy in Acute Ischemic Stroke due to Large Vessel Occlusion Trial in the Extended Time Window (RESILIENT- Extend)
- Multi-Arm Optimization of Stroke Thrombolysis (MOST) Trial
Thursday Main Event | 11 a.m.-12:30 p.m. | Thursday, Feb. 8
- Intravenous Tirofiban Reduces Early Neurological Deterioration in Acute Ischemic Stroke: The Trend Randomized Controlled Clinical Trial
- Uric Acid Supplementation Provides Cerebroprotection Across Different Animal Species, Sex, Age and Comorbidities: A Report From the Stroke Preclinical Assessment Network (SPAN)
- Rescue on Reperfusion Damage in Cerebral Infarction by Nelonemdaz: A Phase 3 Trial
- Effect of an Artificial Intelligence-Based Clinical Decision Support System on Stroke Care Quality and Outcomes in Patients With Acute Ischemic Stroke (Golden Bridge II): A Cluster-Randomized Clinical Trial
Closing Main Event | 11 a.m.-1:30 p.m. | Friday, Feb. 9
- The EMBOLISE Study: Embolization of the Middle Meningeal Artery With OnyxTM Liquid Embolic System in the Treatment of Subacute and Chronic Subdural Hematoma
- The MAGIC-MT Trial: Managing Non-Acute Subdural Hematoma Using Liquid Materials: A Chinese Randomized Trial of Middle Meningeal Artery Treatment
- Antithrombotic Treatment for Stroke Prevention in Cervical Artery Dissection: The STOP-CAD Study
- STEM (The Squid Trial for the Embolization of the MMA for the Treatment of CSDH)
- Delayed Therapy With Humanized Anti-Sdc2 mAb Prevents Formation of Vasogenic Edema and Promotes Neuroprotection in Non-Human Primates With Ischemic Stroke
- Tenecteplase Thrombolysis for Stroke Up to 24 Hours After Onset With Perfusion Imaging Selection: The CHABLIS-T II Randomized Clinical Trial
- Machine Learning Algorithms for Autonomous Detection of Stroke Symptoms and Bell's Palsy
- Reteplase Treating Patients With Acute Ischemic Stroke (RAISE): A Phase 3, Multicenter, Open-Label, Randomized Controlled, Non-Inferiority Trial
- Dual Antiplatelet Therapy and Immediate Intensive Statin in Mild Ischemic Stroke or Transient Ischemic Attack: The INSPIRES Randomized Clinical Trial
- Long-Term Outcomes and EVT Treatment Effect From Randomized Controlled Trial of Endovascular Thrombectomy for Large Ischemic Strokes: SELECT2
Click here for more information about Late-Breaking Science and Concurrent Oral Abstract Sessions at ISC24.
